Literature DB >> 9537029

A primary immune response to dextran B512 is followed by a period of antigen-specific immunosuppression caused by autoanti-idiotypic antibodies.

C Fernandez1, G Möller.   

Abstract

After a primary immune response to the alpha 1-6 epitope of dextran B512, dextran high responder strains exhibit a specific inability to produce IgM and IgG antibodies against this epitope, although they gave an expected secondary response to horse erythrocytes. Spleen cells from dextran-primed and-suppressed mice responded well to dextran after transfer to lethally irradiated previously untreated mice, indicating that tolerance or exhaustive proliferation of dextran reactive B cells is not responsible. Thymus-dependent dextran-protein conjugates also induced specific suppression. Suppression to both dextran and horse erythrocytes could be passively transferred into untreated recipients with immune serum. However, after absorption with horse erythrocytes and dextran, passive serum transfer only suppressed the response to dextran. It is suggested that the specific immunosuppression was caused by the appearance of autoanti-idiotypic antibodies directed against the immunoglobulin receptors of dextran-reactive B cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 9537029     DOI: 10.1111/j.1365-3083.1980.tb00208.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Genetics of the anti-dextran B512 and the autoanti-idiotypic response: codominant expression in F1 hybrids and dichotomy of response and allotype-linked idiotype.

Authors:  C Fernandez; O Mäkelä; G Möller
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Role of antigen and antibody in the regulation of the immune response.

Authors:  G Möller
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

3.  Immunogenicity of bacterial carbohydrates: cholera toxin modulates the immune response against dextran B512.

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.